Roifman Maian, Brunner Han, Lohr Jamie, Mazzeu Juliana, Chitayat David
Division of Clinical and Metabolic Genetics Department of Paediatrics The Hospital for Sick Children; Prenatal Diagnosis and Medical Genetics Program Department of Obstetrics and Gynecology Mount Sinai Hospital; University of Toronto Toronto, Canada
Department of Human Genetics Radboud University Medical Center Nijmegen, the Netherlands
Autosomal dominant Robinow syndrome (ADRS) is characterized by skeletal findings (short stature, mesomelic limb shortening predominantly of the upper limbs, and brachydactyly), genital abnormalities (in males: micropenis / webbed penis, hypoplastic scrotum, cryptorchidism; in females: hypoplastic clitoris and labia majora), dysmorphic facial features (widely spaced and prominent eyes, frontal bossing, anteverted nares, midface retrusion), dental abnormalities (including malocclusion, crowding, hypodontia, late eruption of permanent teeth), bilobed tongue, and occasional prenatal macrocephaly that persists postnatally. Less common findings include renal anomalies, radial head dislocation, vertebral abnormalities such as hemivertebrae and scoliosis, nail dysplasia, cardiac defects, cleft lip/palate, and (rarely) cognitive delay. When present, cardiac defects are a major cause of morbidity and mortality. A variant of Robinow syndrome, associated with osteosclerosis and caused by a heterozygous pathogenic variant in , is characterized by normal stature, persistent macrocephaly, increased bone mineral density with skull osteosclerosis, and hearing loss, in addition to the typical features described above.
DIAGNOSIS/TESTING: The diagnosis of autosomal dominant Robinow syndrome is established in a proband with typical suggestive findings and/or by the identification of a heterozygous pathogenic variant in , , or through molecular genetic testing.
Corrective surgeries as needed for cryptorchidism, abnormal penile insertion / penoscrotal position, and cleft lip/palate. Hormone therapy may be helpful for males with micropenis. Orthodontic treatment is typically required. Measurement of head circumference regularly in infancy and throughout childhood. Developmental assessment every three months in infancy and every six months to one year thereafter, or more frequently as needed if cognitive delays are identified. Dental evaluation every six to 12 months or as recommended. Periodic hearing assessments in childhood. Regular cardiac and renal assessment as needed by respective specialists if abnormalities are identified. Evaluation of the sibs of a proband in order to identify as early as possible those who would benefit from institution of treatment and surveillance. Pregnancy in affected women appears to be generally uncomplicated. For an affected fetus, cesarean section may be required for abnormal presentation and/or cephalopelvic disproportion.
ADRS is inherited in an autosomal dominant manner. A proband may have the disorder as a result of either an inherited or pathogenic variant. Each child of an individual with ADRS has a 50% chance of inheriting the pathogenic variant; however, the severity of the clinical manifestations cannot be predicted from the results of molecular genetic testing. Prenatal testing for a pregnancy at increased risk is possible if the , , or pathogenic variant has been identified in an affected family member.
常染色体显性遗传性罗宾诺综合征(ADRS)的特征包括骨骼表现(身材矮小、中肢短小,以上肢为主,以及短指畸形)、生殖器异常(男性:小阴茎/蹼状阴茎、阴囊发育不全、隐睾症;女性:阴蒂发育不全和大阴唇发育不全)、面部畸形特征(眼距宽且突出、额部隆起、鼻孔前倾、面中部后缩)、牙齿异常(包括错牙合、牙列拥挤、缺牙、恒牙萌出延迟)、双叶舌,以及偶尔出现的产前巨头畸形并持续至出生后。较少见的表现包括肾脏异常、桡骨头脱位、椎体异常如半椎体和脊柱侧弯、指甲发育异常、心脏缺陷、唇腭裂,以及(罕见)认知延迟。若存在心脏缺陷,则是发病和死亡的主要原因。罗宾诺综合征的一种变异型,与骨硬化相关,由 中的杂合致病变异引起,除上述典型特征外,其特点为身材正常、持续巨头畸形、骨矿物质密度增加伴颅骨骨硬化以及听力丧失。
诊断/检测:常染色体显性遗传性罗宾诺综合征的诊断在具有典型提示性表现的先证者中确立,和/或通过分子遗传学检测在 、 或 中鉴定出杂合致病变异。
根据需要对隐睾症、阴茎插入异常/阴茎阴囊位置异常以及唇腭裂进行矫正手术。激素治疗可能对小阴茎男性有帮助。通常需要正畸治疗。在婴儿期及整个儿童期定期测量头围。婴儿期每三个月进行一次发育评估,此后每六个月至一年进行一次,或如果发现认知延迟则根据需要更频繁进行。每六至十二个月或根据建议进行牙科评估。儿童期定期进行听力评估。如果发现异常,由相应专科医生根据需要定期进行心脏和肾脏评估。对先证者的同胞进行评估,以便尽早确定那些将从治疗和监测中受益的人。受影响女性的妊娠通常似乎无并发症。对于受影响的胎儿,若出现胎位异常和/或头盆不称可能需要剖宫产。
ADRS 以常染色体显性方式遗传。先证者可能由于遗传或 致病变异而患有该疾病。ADRS 患者的每个孩子有 50%的机会继承致病变异;然而,无法根据分子遗传学检测结果预测临床表现的严重程度。如果在受影响的家庭成员中鉴定出 、 或 致病变异,则对风险增加的妊娠进行产前检测是可行的。